MiR-Synth: A computational resource for the design of multi-site multi-target synthetic miRNAs

Nucleic Acids Research

Volumn 42, Issue 9, 2014, Pages 5416-5425

  Laganà, Alessandro ^a   Acunzo, Mario ^a   Romano, Giulia ^a   Pulvirenti, Alfredo ^b   Veneziano, Dario ^a,b   Cascione, Luciano ^c   Giugno, Rosalba ^b   Gasparini, Pierluigi ^a   Shasha, Dennis ^d   Ferro, Alfredo ^b   Croce, Carlo Maria ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF CATANIA   (Italy)

^c INSTITUTE OF ONCOLOGY RESEARCH   (Switzerland)

^d POLYTECHNIC UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; MICRORNA; RNA; SHORT HAIRPIN RNA; SMALL INTERFERING RNA;

3' UNTRANSLATED REGION; ARTICLE; CANCER PATIENT; DATA BASE; GENE CONTROL; GENE DELETION; GENE EXPRESSION; GENE MUTATION; GENE SEQUENCE; GENE TARGETING; HELA CELL LINE; HUMAN; HUMAN CELL; LUNG CANCER; MIR-SYNTH DATA BASE; PRIORITY JOURNAL; RNA EXTRACTION; RNA INTERFERENCE;

3' UNTRANSLATED REGIONS; BASE SEQUENCE; GENE EXPRESSION; GENE KNOCKDOWN TECHNIQUES; GENES, REPORTER; HEK293 CELLS; HELA CELLS; HUMANS; LUCIFERASES, RENILLA; MICRORNAS; PROTO-ONCOGENE PROTEINS C-MET; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA INTERFERENCE; SOFTWARE;

EID: 84901382023     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gku202     Document Type: Article

References (38)

1. Petrelli, A. and Valabrega, G. (2009) Multitarget drugs: The present and the future of cancer therapy. Expert Opin. Pharmacother., 10, 589-600.
2. McCarty, M.F. (2004) Targeting multiple signaling pathways as a strategy for managing prostate cancer: Multifocal signal modulation therapy. Integr. Cancer Ther., 3, 349-380.
3. Sinha, G. (2012) Interest resparks in RNAi. Nat. Biotechnol., 30, 1012.
4. Davis, M.E., Zuckerman, J.E., Choi, C.H.J., Seligson, D., Tolcher, A., Alabi, C.A., Yen, Y., Heidel, J.D. and Ribas, A. (2010) Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles. Nature, 464, 1067-1070.
5. Rao, D.D., Vorhies, J.S., Senzer, N. and Nemunaitis, J. (2009) siRNA vs. shRNA: Similarities and differences. Adv. Drug Deliv. Rev., 61, 746-759.
6. Davidson, B.L. and McCray, P.B. (2011) Current prospects for RNA interference-based therapies. Nat. Rev. Genet., 12, 329-340.
7. Cheng, T.L., Teng, C.F., Tsai, W.H., Yeh, C.W., Wu, M.P., Hsu, H.C., Hung, C.F. and Chang, W.T. (2009) Multitarget therapy of malignant cancers by the head-To-Tail tandem array multiple shRNAs expression system. Cancer Gene Ther., 16, 516-531.
8. ter Brake, O., Konstantinova, P., Ceylan, M. and Berkhout, B. (2006) Silencing of HIV-1 with RNA interference: A multiple shRNA approach. Mol. Ther., 14, 883-892.
9. Tiemann, K., Hohn, B., Ehsani, A., Forman, S.J., Rossi, J.J. and Saetrom, P. (2010) Dual-Targeting siRNAs. RNA, 16, 1275-1284.
10. Passioura, T., Gozar, M.M., Goodchild, A., King, A., Arndt, G.M., Poidinger, M., Birkett, D.J. and Rivory, L.P. (2009) Interfering ribonucleic acids that suppress expression of multiple unrelated genes. BMC Biotechnol., 9, 57.
11. Bartel, D.P. (2009) MicroRNAs: Target recognition and regulatory functions. Cell, 136, 215-233.
12. Acunzo, M., Visone, R., Romano, G., Veronese, A., Lovat, F., Palmieri, D., Bottoni, A., Garofalo, M., Gasparini, P., Condorelli, G. et al. (2012) miR-130a targets MET and induces TRAIL-sensitivity in NSCLC by downregulating miR-221 and 222. Oncogene, 31, 634-642.
13. Acunzo, M., Romano, G., Palmieri, D., Laganá, A., Garofalo, M., Balatti, V., Drusco, A., Chiariello, M., Nana-Sinkam, P. and Croce, C.M. (2013) Cross-Talk between MET and EGFR in non-small cell lung cancer involves miR-27a and Sprouty2. Proc. Natl. Acad. Sci. U. S. A., 110, 8573-8578.
14. Thomas, M., Lieberman, J. and Lal, A. (2010) Desperately seeking microRNA targets. Nat. Struct. Mol. Biol., 17, 1169-1174.
15. Grimson, A., Farh, K.K-H., Johnston, W.K., Garrett-Engele, P., Lim, L.P. and Bartel, D.P. (2007) MicroRNA targeting specificity in mammals: Determinants beyond seed pairing. Mol. Cell, 27, 91-105.
16. Petryszak, R., Burdett, T., Fiorelli, B., Fonseca, N.A., Gonzalez-Porta, M., Hastings, E., Huber, W., Jupp, S., Keays, M., Kryvych, N. et al. (2013) Expression Atlas update-A database of gene and transcript expression from microarray-And sequencing-based functional genomics experiments. Nucleic Acids Res., doi:10.1093/nar/gkt1270.
17. Reynolds, A., Leake, D., Boese, Q., Scaringe, S., Marshall, W.S. and Khvorova, A. (2004) Rational siRNA design for RNA interference. Nat. Biotechnol., 22, 326-330.
18. Dykxhoorn, D.M., Novina, C.D. and Sharp, P.A. (2003) Killing the messenger: Short RNAs that silence gene expression. Nat. Rev. Mol. Cell Biol., 4, 457-467.
19. Betel, D., Koppal, A., Agius, P., Sander, C. and Leslie, C. (2010) Comprehensive modeling of microRNA targets predicts functional non-conserved and non-canonical sites. Genome Biol., 11(8), R90.
20. Shao, Y., Chan, C.Y., Maliyekkel, A., Lawrence, C.E., Roninson, I.B. and Ding, Y. (2007) Effect of target secondary structure on RNAi efficiency. RNA, 13, 1631-1640. (Pubitemid 47481671
21. Kertesz, M., Iovino, N., Unnerstall, U., Gaul, U. and Segal, E. (2007) The role of site accessibility in microRNA target recognition. Nat. Genet., 39, 1278-1284.
22. Sun, G., Li, H. and Rossi, J.J. (2010) Sequence context outside the target region influences the effectiveness of miR-223 target sites in the RhoB 3'UTR. Nucleic Acids Res., 38(1), 239-252.
23. Wang, Y. and Witten, I.H. (1997) Inducing model trees for continuous classes. In: Van Someren, M and Widmer, G (eds). Poster Papers of the 9th European Conference on Machine Learning (ECML 97).Prague, Czech Republic, 128-137.
24. Hothorn, T., Hornik, K. and Zeileis, A. (2006) Unbiased recursive partitioning: A conditional inference framework. J. Comput. Graph. Stat., 15, 651-674.
25. Hsu, S.D., Lin, F.M., Wu, W.Y., Liang, C., Huang, W.C., Chan, W.L., Tsai, W.T., Chen, G.Z., Lee, C.J., Chiu, C.M. et al. (2010) miRTarBase: A database curates experimentally validated microRNA-Target interactions. Nucleic Acids Res., 39, D163-D169.
26. Suda, K., Tomizawa, K., Osada, H., Maehara, Y., Yatabe, Y., Sekido, Y. and Mitsudomi, T. (2011) Conversion from the "oncogene addiction" to "drug addiction" by intensive inhibition of the EGFR and MET in lung cancer with activating EGFR mutation. Lung Cancer, doi:10.1016/j.lungcan.2011. 11.007.
27. Haas, U., Sczakiel, G. and Laufer, S.D. (2012) MicroRNA-mediated regulation of gene expression is affected by disease-Associated SNPs within the 3'-UTR via altered RNA structure. RNA Biol., 9, 924-937.
28. Saunders, M.A., Liang, H. and Li, W.-H. (2007) Human polymorphism at microRNAs and microRNA target sites. Proc. Natl. Acad. Sci. U. S. A., 104, 3300-3305.
29. Dykxhoorn, D.M. and Lieberman, J. (2005) The silent revolution: RNA interference as basic biology, research tool, and therapeutic. Annu. Rev. Med., 56, 401-423.
30. Rao, D.D., Wang, Z., Senzer, N. and Nemunaitis, J. (2013) RNA interference and personalized cancer therapy. Discov. Med., 15, 101-110.
31. Daka, A. and Peer, D. (2012) RNAi-based nanomedicines for targeted personalized therapy. Adv. Drug Deliv. Rev., 64, 1508-1521.
32. Kesharwani, P., Gajbhiye, V. and Jain, N.K. (2012) A review of nanocarriers for the delivery of small interfering RNA. Biomaterials, 33, 7138-7150.
33. Breitbach, C.J., Burke, J., Jonker, D., Stephenson, J., Haas, A.R., Chow, L.Q.M., Nieva, J., Hwang, T.-H., Moon, A., Patt, R. et al. (2011) Intravenous delivery of a multi-mechanistic cancer-Targeted oncolytic poxvirus in humans. Nature, 477, 99-102.
34. Akhtar, S. (2009) Oral delivery of siRNA and antisense oligonucleotides. J Drug Target., 17, 491-495.
35. Aouadi, M., Tesz, G.J., Nicoloro, S.M., Wang, M., Chouinard, M., Soto, E., Ostroff, G.R. and Czech, M.P. (2009) Orally delivered siRNA targeting macrophage Map4k4 suppresses systemic inflammation. Nature, 458, 1180-1184.
36. Zhang, L., Hou, D., Chen, X., Li, D., Zhu, L., Zhang, Y., Li, J., Bian, Z., Liang, X., Cai, X. et al. (2012) Exogenous plant MIR168a specifically targets mammalian LDLRAP1: Evidence of cross-kingdom regulation by microRNA. Cell Res., 22, 107-126.
37. Jackson, A.L., Burchard, J., Schelter, J., Chau, B.N., Cleary, M., Lim, L. and Linsley, P.S. (2006) Widespread siRNA off-Target' transcript silencing mediated by seed region sequence complementarity. RNA, 12, 1179-1187.
38. Birmingham, A., Anderson, E.M., Reynolds, A., Ilsley-Tyree, D., Leake, D., Fedorov, Y., Baskerville, S., Maksimova, E., Robinson, K., Karpilow, J. et al. (2006) 3-UTR seed matches, but not overall identity, are associated with RNAi off-Targets. Nat. Methods, 3, 199-204.